VolitionRx Ltd
VNRX
25 hedge funds and large institutions have $12M invested in VolitionRx Ltd in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 6 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
7% more capital invested
Capital invested by funds: $11.2M → $12M (+$765K)
0.12% more ownership
Funds ownership: 0.97% → 1.09% (+0.12%)
7% less funds holding
Funds holding: 27 → 25 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Lagoda Investment Management
New York
|
+$1.56M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$41.4K |
| 3 |
Squarepoint
New York
|
+$36.2K |
| 4 |
Bank of New York Mellon
New York
|
+$18.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$164K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$40.9K |
| 3 |
Millennium Management
New York
|
-$29.7K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$16.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$14.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
26
Bridgeway Capital Management
Houston,
Texas
| – | -$12.2K | -1,014 | Closed |
|
|
VF
27
Virtu Financial
New York
| – | -$7K | -612 | Closed |
|
28
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$6.79K | -566 | Closed |
|
29
Citigroup
New York
| – | -$889 | -74 | Closed |
|
30
Simplex Trading
Chicago,
Illinois
| – | +$95 | +8 | +42% |
|
VNRX Hedge Fund Activity: Q1 2025 in Review
25 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2025, worth a combined $12M — up 6.8% from $11.2M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of VNRX and 4 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 8 added.
The largest buyer was Lagoda Investment Management, adding an estimated $1.56M. The largest seller was Armistice Capital, cutting an estimated $164K.
- 25 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2025, down from 27 in Q4 2024.
- Funds reported $12M of VolitionRx Ltd stock for Q1 2025, up 6.8% quarter-over-quarter.
- 4 funds opened new VolitionRx Ltd positions in Q1 2025 and 6 closed out, a net change of -2 holders.
- The largest VolitionRx Ltd buyer in Q1 2025 was Lagoda Investment Management, an estimated $1.56M added.
- The largest VolitionRx Ltd seller in Q1 2025 was Armistice Capital, an estimated $164K sold.
Based on aggregated 13F filings for Q1 2025.